Patent · US Active

Two-way, portable riboswitch mediated gene expression control device

US9222093B2 · kind B2 · utility

3Cited by
1References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 27, 2012
Grant dateDec 29, 2015
Priority date
Expiry dateMay 3, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/10
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

A regulatable gene expression construct comprising a nucleic acid molecule comprising a two-way riboswitch operably linked to a target sequence. Also provided is a library screening strategy for efficient creation of target-specific riboswitches. A theophylline-repressible and IPTG-inducible riboswitch device achieves portable control of gene expression control in a ‘two-way’ manner. The default state of target genes is ON; the targets are switched off by adding theophylline, and switched back to the ON-state by adding IPTG without changing growth medium. The riboswitch device regulates gene expression in a portable, adjustable, and two-way manner with a variety of scientific and biotechnological applications.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.